Prescription Weight Loss Drugs for All?
January 24, 2025
53 min
Full
386 of 464
January 24, 2025
Prescription Weight Loss Drugs for All?
0:00 / 53:15
Excerpt playback isn’t available for this episode — use the full-episode link.
Search the Record
Moment search isn’t open for this episode yet
When it opens, you’ll be able to type any phrase and jump straight to the second it was said.
Open to Debate Episodes Around January 24, 2025
Episode 386 of 464 — walk the feed in the order it was published.
53:15Can America and Its Allies Tolerate A Nuclear Iran, or Is It Time to Stop Them Now?
53:15This episodePrescription Weight Loss Drugs for All?
Summary
GLP-1 drugs like Ozempic, Wegovy, and Mounjaro have opened doors for people to lose weight. Should everyone have the option to take it? Those arguing “yes” say obesity needs to be treated using every available tool, especially for people for whom diet, lifestyle changes, and exercise aren’t enough. Those arguing “no” are concerned about its side effects and the risks if people don’t take them as directed. Now we debate: should prescription weight loss drugs be available for all?
Arguing Yes: David Allison, Obesity Researcher; Dean and Distinguished Professor at the Indiana University School of Public Health-Bloomington
Arguing No: Stuart W. Flint, Associate Professor of the Psychology of Obesity at the University of Leeds
Emmy award-winning journalist John Donvan moderates
Learn more about your ad choices. Visit podcastchoices.com/adchoices
Episode details and artwork are published by the show’s own feed. Sentinel plays short cited excerpts and links every episode back to its publisher.